- Home
- STTK vs FCCO Comparison
STTK vs FCCO Comparison
Compare STTK & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- FCCO
- Stock Information
- Founded
- STTK 2016
- FCCO 1994
- Country
- STTK United States
- FCCO United States
- Employees
- STTK N/A
- FCCO N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- FCCO Major Banks
- Sector
- STTK Health Care
- FCCO Finance
- Exchange
- STTK Nasdaq
- FCCO Nasdaq
- Market Cap
- STTK 37.6M
- FCCO 182.4M
- IPO Year
- STTK 2020
- FCCO 1998
- Fundamental
- Price
- STTK $0.83
- FCCO $24.98
- Analyst Decision
- STTK Hold
- FCCO Strong Buy
- Analyst Count
- STTK 4
- FCCO 2
- Target Price
- STTK $3.00
- FCCO $30.00
- AVG Volume (30 Days)
- STTK 423.3K
- FCCO 75.7K
- Earning Date
- STTK 07-31-2025
- FCCO 07-23-2025
- Dividend Yield
- STTK N/A
- FCCO 2.37%
- EPS Growth
- STTK N/A
- FCCO 37.48
- EPS
- STTK N/A
- FCCO 1.98
- Revenue
- STTK $4,606,000.00
- FCCO $67,933,000.00
- Revenue This Year
- STTK N/A
- FCCO $18.61
- Revenue Next Year
- STTK N/A
- FCCO $11.88
- P/E Ratio
- STTK N/A
- FCCO $12.79
- Revenue Growth
- STTK 69.65
- FCCO 16.46
- 52 Week Low
- STTK $0.69
- FCCO $16.40
- 52 Week High
- STTK $4.99
- FCCO $27.96
- Technical
- Relative Strength Index (RSI)
- STTK 38.86
- FCCO 65.01
- Support Level
- STTK $0.75
- FCCO $25.01
- Resistance Level
- STTK $0.85
- FCCO $25.95
- Average True Range (ATR)
- STTK 0.09
- FCCO 0.49
- MACD
- STTK -0.01
- FCCO 0.18
- Stochastic Oscillator
- STTK 9.59
- FCCO 79.89
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.